[go: up one dir, main page]

IL127113A - 2-phenyl-1,2-benzisoselenazol-3 (2h)-one compositions for the treatment of alzheimer's disease - Google Patents

2-phenyl-1,2-benzisoselenazol-3 (2h)-one compositions for the treatment of alzheimer's disease

Info

Publication number
IL127113A
IL127113A IL12711397A IL12711397A IL127113A IL 127113 A IL127113 A IL 127113A IL 12711397 A IL12711397 A IL 12711397A IL 12711397 A IL12711397 A IL 12711397A IL 127113 A IL127113 A IL 127113A
Authority
IL
Israel
Prior art keywords
alzheimer
phenyl
treatment
benzisoselenazol
disease
Prior art date
Application number
IL12711397A
Other languages
English (en)
Other versions
IL127113A0 (en
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of IL127113A0 publication Critical patent/IL127113A0/xx
Publication of IL127113A publication Critical patent/IL127113A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12711397A 1996-08-27 1997-04-07 2-phenyl-1,2-benzisoselenazol-3 (2h)-one compositions for the treatment of alzheimer's disease IL127113A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27
PCT/DE1997/000701 WO1998008511A1 (de) 1996-08-27 1997-04-07 Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-one zur herstellung einer pharmazeutischen zubereitung für die behandlung der alzheimer-krankheit

Publications (2)

Publication Number Publication Date
IL127113A0 IL127113A0 (en) 1999-09-22
IL127113A true IL127113A (en) 2003-07-06

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12711397A IL127113A (en) 1996-08-27 1997-04-07 2-phenyl-1,2-benzisoselenazol-3 (2h)-one compositions for the treatment of alzheimer's disease

Country Status (28)

Country Link
US (1) US5948800A (xx)
EP (1) EP0826370B1 (xx)
KR (1) KR20000035859A (xx)
CN (1) CN1112922C (xx)
AT (1) ATE219361T1 (xx)
AU (2) AU3866997A (xx)
BR (1) BR9711259A (xx)
CA (1) CA2213794C (xx)
CZ (1) CZ295364B6 (xx)
DE (2) DE59707550D1 (xx)
DK (1) DK0826370T3 (xx)
EE (1) EE03953B1 (xx)
ES (1) ES2177849T3 (xx)
FI (1) FI119622B (xx)
HU (1) HU225264B1 (xx)
IL (1) IL127113A (xx)
LT (1) LT4602B (xx)
LV (1) LV12251B (xx)
NO (1) NO312812B1 (xx)
NZ (1) NZ332292A (xx)
PL (1) PL188481B1 (xx)
PT (1) PT826370E (xx)
SI (1) SI9720060B (xx)
TR (1) TR199700858A2 (xx)
TW (1) TW501925B (xx)
UA (1) UA59367C2 (xx)
WO (2) WO1998008511A1 (xx)
ZA (1) ZA977644B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE190487T1 (de) * 1993-10-27 2000-04-15 Daiichi Seiyaku Co Granuläre zubereitung
JP2000016935A (ja) * 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
US7671211B1 (en) 1999-03-31 2010-03-02 Arne Holmgren Substrates for thioredoxin reductase
WO2003010153A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
WO2003010154A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
WO1998008831A1 (en) 1998-03-05
ATE219361T1 (de) 2002-07-15
AU3529897A (en) 1998-03-05
NO973912D0 (no) 1997-08-26
KR20000035859A (ko) 2000-06-26
FI119622B (fi) 2009-01-30
CN1223580A (zh) 1999-07-21
DE59707550D1 (de) 2002-07-25
CZ295364B6 (cs) 2005-07-13
UA59367C2 (uk) 2003-09-15
EE03953B1 (et) 2003-02-17
HUP9903213A3 (en) 2000-12-28
AU725534B2 (en) 2000-10-12
NO973912L (no) 1998-03-02
LV12251A (lv) 1999-04-20
HU225264B1 (en) 2006-08-28
FI982689L (fi) 1998-12-11
CA2213794A1 (en) 1998-02-27
CA2213794C (en) 2006-10-03
ZA977644B (en) 1999-02-26
CZ31799A3 (cs) 1999-11-17
EP0826370B1 (de) 2002-06-19
EE9900007A (et) 1999-06-15
SI9720060B (en) 2001-12-31
PT826370E (pt) 2002-10-31
PL321796A1 (en) 1998-03-02
LV12251B (lv) 1999-08-20
FI982689A0 (fi) 1998-12-11
WO1998008511A1 (de) 1998-03-05
LT4602B (lt) 2000-01-25
HUP9903213A1 (en) 2000-07-28
EP0826370A1 (de) 1998-03-04
TR199700858A2 (xx) 1998-03-21
IL127113A0 (en) 1999-09-22
HK1020317A1 (en) 2000-04-14
ES2177849T3 (es) 2002-12-16
NZ332292A (en) 2001-07-27
PL188481B1 (pl) 2005-02-28
BR9711259A (pt) 1999-08-17
SI9720060A (sl) 1999-06-30
US5948800A (en) 1999-09-07
DE19733690A1 (de) 1998-03-26
DK0826370T3 (da) 2002-10-07
CN1112922C (zh) 2003-07-02
NO312812B1 (no) 2002-07-08
AU3866997A (en) 1998-03-19
TW501925B (en) 2002-09-11
LT99016A (en) 1999-10-25

Similar Documents

Publication Publication Date Title
IL127113A (en) 2-phenyl-1,2-benzisoselenazol-3 (2h)-one compositions for the treatment of alzheimer's disease
AU1808488A (en) Compounds for the treatment of alzheimer's disease
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
HUT58204A (en) Magnesium-pyridoxale-5'-phosphate-glutaminate for preventing diseases originated from blood-vessel-alternations
GR3032041T3 (en) Idebenone compositions for treating Alzheimer's disease.
IL134263A0 (en) Use of phanquinone for the treatment of alzheimer's disease
CA2078700A1 (en) Imidazolylmethyl-pyridines
ZA961897B (en) 6,7-substituted-2-aminotetralines and use thereof
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
HUP0103149A3 (en) Pharmaceutical composition for treatment of alzheimer's disease
HK2794A (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ZA915462B (en) Composition for the treatment of alzheimer's disease and process for preparing the same
AU2002318888A1 (en) Metal Chelators for use in the treatment of Alzheimer's Disease
IL88936A0 (en) Compositions for the prevention and treatment of periodontal disease

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees